Skip to content

Clinical trials

Phase 3 Glomerulonephritis, IGA trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Phase: Phase 3 Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20141
20201
20213
20222
20233
20244
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Active, not recruiting8
Completed3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Alexion Pharmaceuticals, Inc.2
Air Force Military Medical University, China1
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Biocity Biopharmaceutics Co., Ltd.1
Biogen1
Chengdu Suncadia Medicine Co., Ltd.1
Everest Medicines (Singapore) Pte. Ltd.1
Haisco Pharmaceutical Group Co., Ltd.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA22
Glomerulonephritis5
Proteinuria5
Renal Insufficiency, Chronic5
Kidney Diseases3
Urologic Diseases3
Autoimmune Diseases1
IgA Vasculitis1
Immune System Diseases1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.